arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

TherapeuticsMD, Inc.

TXMD

$2.17 ▲ +0.03 (+1.40%) at close

16 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

TherapeuticsMD, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $25.1M

Dividend Yield —

Revenue Growth 71.6% ↗

Op. Margin -145.3% ↗

ROIC -12.9% ↗

FCF / Share None

Trailing P/E —

Price / Book 0.9x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

16-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$3.02M

↑ +71.6% —

Net Income Profit after all expenses

$-569.00K

↑ +73.9% —

Operating Margin Operating profit as % of sales

-145.3%

↑ +46.3% 1th

Long-Term Debt Long-term obligations

$188.27M

↓ -20.8% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns

Financial Health ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Revenue Growth YoY (%)	71.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+795%)	35.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+341%)	-98.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1327%)	2619.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+32639%)	-96.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1300%)	30.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+283%)	208.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2505%)	-4.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-151%)	-13.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-267%)	-3.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-149%)	34.1% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+326%)	71.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+790%)	129.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+1523%)	82.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+935%)	—	—
EPS Growth YoY (%)	73.7% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	80.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	73.9% Excellent Excellent Year-over-year change in net income	78.8% Excellent Excellent Year-over-year change in net income	N/M	N/M	6.1% Fair ↑ Fair Improving Year-over-year change in net income	-4.2% Weak ↑ Weak Improving Year-over-year change in net income	-32.8% Weak ↓ Weak Declining Year-over-year change in net income	-72.4% Weak ↓ Weak Declining Year-over-year change in net income	14.4% Fair ↑ Fair Improving Year-over-year change in net income	-5.6% Weak ↑ Weak Improving Year-over-year change in net income	-56.9% Weak ↑ Weak Improving Year-over-year change in net income	-90.8% Weak ↑ Weak Improving Year-over-year change in net income	19.1% Good ↑ Good Improving Year-over-year change in net income	-172.0% Weak Weak Year-over-year change in net income	-350.3% Weak Weak Year-over-year change in net income	—
Revenue CAGR 3Y (%)	-64.9% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	-11.9% Weak ↑ Weak Improving Compound annual revenue growth over 3 years	-72.8% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	12.1% Good ↓ Good Declining Compound annual revenue growth over 3 years	-45.7% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	57.0% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	36.9% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-7.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	3.7% Caution ↓ Caution Declining Compound annual revenue growth over 3 years	30.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	74.1% Excellent Excellent Compound annual revenue growth over 3 years	93.1% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	-45.8% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-48.7% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	-39.5% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	33.1% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	-33.2% Weak ↓ Weak Declining Compound annual revenue growth over 5 years	26.4% Excellent ↑ Excellent Improving Compound annual revenue growth over 5 years	27.0% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	12.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	34.5% Excellent Excellent Compound annual revenue growth over 5 years	56.1% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Operating Margin (%) (%)	-145.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1068%)	-270.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1902%)	—	1.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-89%)	—	-239.8% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1698%)	-304.6% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2130%)	—	-462.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3185%)	-466.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3208%)	-422.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2920%)	-359.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2498%)	-294.1% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2061%)	-423.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2920%)	-259.9% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1833%)	—
Effective Tax Rate (%) (%)	—	1.3% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	-18.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-257%)	-123.9% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1132%)	—	—	—	-282.9% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2458%)	-354.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3057%)	—	-458.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3921%)	-464.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3969%)	-422.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3620%)	-360.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3107%)	-323.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2799%)	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	-246.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-338.7% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	—	-454.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-359.3% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-393.2% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-303.1% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-237.1% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-335.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-239.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	—	—	—	—	—	0.87x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.73x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.36x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.39x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Return on Invested Capital (%)	-12.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	2.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-66.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-108.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-58.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-60.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-47.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-55.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-106.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-88.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-37.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	890.2% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	250.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-11.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-19.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	1.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-47.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-85.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-56.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-61.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-54.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-63.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-115.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-91.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-41.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-272.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-377.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	-2.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-114%)	-8.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-153%)	-35.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-334%)	—	184.2% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1128%)	148.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+887%)	—	-136.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1007%)	-59.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-495%)	-70.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-570%)	-134.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-999%)	-112.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-847%)	-52.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-446%)	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Debt to Equity (x)	—	—	—	—	-2.01x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-435%)	-1.92x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-419%)	21.15x Weak Weak Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+3426%)	0.75x Fair Fair Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Above avg (+25%)	—	—	—	—	—	—	—	—
Interest Coverage (x)	-548.75x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-501.05x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-51.16x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	0.03x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2.42x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-5.44x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.70x Weak Weak Operating income divided by interest expense Optimal: > 5x	-27.84x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-46.35x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-13.54x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-8.48x Weak Weak Operating income divided by interest expense Optimal: > 5x	-84.30x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	—	$-5.06M	$-4.33M	—	$188.27M	$237.70M	$194.63M	$73.38M	—	—	—	—	—	—	$-126.42K	$-422.94K
Debt / EBITDA (x)	—	—	—	—	-2.38x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.54x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-1.29x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.56x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Revenue per Share (USD)	$0.26	—	—	$7.75	$0.32	$11.77	—	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.05	$-0.19	$-0.99	$12.41	$-21.66	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	—	—	—	—	—	$-28.96	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$2.32	$2.37	$2.54	$3.70	$-10.89	$-20.68	$1.70	$20.28	$30.01	$32.41	$17.72	$15.50	$18.86	$-0.72	$-1.03	—
Tangible Book Value per Share (USD)	$2.00	$2.00	$2.01	$2.97	$-11.72	$-27.60	$0.73	$19.43	$29.30	$31.80	$17.27	$15.11	$18.63	$-0.84	$-1.03	—
Basic Weighted Avg Shares (shares)	11.57M	11,532	10,441	9.03M	7.96M	5.51M	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Working Capital (USD)	$9.66M	$7.09M	$4.94M	$8.51M	$-133.42M	$69.17M	$155.41M	$145.70M	$126.23M	$124.43M	$60.01M	$45.54M	$52.09M	$1.02M	$-1.91M	—
LT Debt (USD)	—	—	—	—	$188.27M	$237.70M	$194.63M	$73.38M	—	—	—	—	—	—	—	—
Total Equity (USD)	$26.88M	$27.37M	$29.29M	$35.14M	$-93.62M	$-124.00M	$9.20M	$97.52M	$129.91M	$127.49M	$63.06M	$48.39M	$54.70M	$-1.43M	$-1.71M	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗	FY 2011 Dec 31, 2011 10-K ↗	FY 2010 Dec 31, 2010 10-K ↗
Sales/Revenue/Turnover (USD)	$3.02M	$1.76M	$1.30M	$69.96M	$2.57M	$64.87M	$49.65M	$16.10M	$16.78M	$19.36M	$20.14M	$15.03M	$8.78M	$3.82M	$2.09M	—
Depreciation Expense (USD)	—	—	—	$600.00K	$400.00K	$800.00K	$415.19K	$181.41K	$141.60K	$77.91K	$29.96K	$28.99K	$47.88K	$27.48K	$54.84K	—
Net Income, GAAP (USD)	$-569.00K	$-2.18M	$-10.28M	$112.00M	$-172.41M	$-183.52M	$-176.14M	$-132.62M	$-76.93M	$-89.88M	$-85.08M	$-54.22M	$-28.42M	$-35.12M	$-12.91M	$-2.87M
Operating Cash Flow (USD)	—	—	—	—	—	$-159.47M	$-165.70M	$-106.81M	$-76.16M	$-69.14M	$-79.04M	$-45.52M	$-20.77M	$-12.74M	$-4.97M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 16 years · 66 quarters

TherapeuticsMD, Inc.

Analytical Summary

16-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare TXMD with peers